You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

 

Online download statistics by month:

Online download statistics by month: May 2021 to July 2022

AbstractFullPdf
May 2021475475195
Jun 2021261260163
Jul 202116516562
Aug 202114214259
Sep 202113213265
Oct 202113013087
Nov 202111511572
Dec 2021767635
Jan 2022717761
Feb 202211211552
Mar 202211311661
Apr 2022808249
May 202210010066
Jun 2022889241
Jul 2022777941
Total213721561109